Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines - Archive ouverte HAL Access content directly
Journal Articles Frontiers in Immunology Year : 2020

Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines

(1, 2) , (1) , (2) , (1, 2) , (1, 2) , (1, 2) , (1, 2)
1
2

Abstract

The rapid spread, severity, and lack of specific treatment for COVID-19 resulted in hasty drug repurposing. Conceptually, trials of antivirals were well-accepted, but twentieth century antimalarials sparked an impassioned global debate. Notwithstanding, antiviral and immunomodulatory effects of aminoquinolines have been investigatedin vitro, in vivoand in clinical trials for more than 30 years. We review the mechanisms of action of (hydroxy)chloroquine on immune cells and networks and discuss promises and pitfalls in the fight against SARS-CoV-2, the agent of the COVID-19 outbreak.

Dates and versions

hal-03149722 , version 1 (23-02-2021)

Identifiers

Cite

Joana Vitte, Moise Michel, Soraya Mezouar, Aissatou Bailo Diallo, Asma Boumaza, et al.. Immune Modulation as a Therapeutic Option During the SARS-CoV-2 Outbreak: The Case for Antimalarial Aminoquinolines. Frontiers in Immunology, 2020, 11, ⟨10.3389/fimmu.2020.02159⟩. ⟨hal-03149722⟩

Collections

CNRS UNIV-AMU
13 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More